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a b s t r a c t
During HIV type 1 (HIV-1) entry, trimers of gp120 bind to CD4 and either the CCR5 or CXCR4 coreceptor
on the target cell. The stoichiometric parameters associated with HIV-1 entry remain unclear. Important
unanswered questions include: how many trimers must attach to CD4 molecules, how many must bind
coreceptors, and how many functional gp120 subunits per trimer are required for entry? We performed
single round infectivity assays with chimeric viruses and compared the experimental relative infectivity
curves with curves generated by mathematical models. Our results indicate that HIV-1 entry requires
only a small number of functional spikes (one or two), that Env trimers may function with fewer than
three active subunits, and that there is no major difference in the stoichiometric requirements for CCR5
vs. CXCR4 mediated HIV-1 entry into host cells.
& 2014 Elsevier Inc. All rights reserved.
Introduction
To infect a target cell, HIV-1 must ﬁrst attach to the cell and then
initiate the fusion of the viral and cellular membranes (LaBranche
et al., 2001). For this purpose, HIV-1 utilizes envelope (Env)
glycoproteins which protrude from the surface of the virus. These
glycoproteins are assembled as trimers which are visible in electron
micrographs and appear as spikes on the surface of the virion. Each
spike is composed of three sets of the non-covalently associated Env
subunits, gp120 and gp41 (Wilen et al., 2012). In the entry process,
gp120 subunits ﬁrst attach to the host cell CD4, and then these CD4-
activated gp120 subunits bind to chemokine receptors, either
CXCR4 or CCR5, which function as co-receptors for HIV-1 (Moore
et al., 1997, 2004; Alkhatib, 2009; Berger, 1988). However, the
stoichiometry of this process is incompletely understood. Important
unanswered questions include: how many spikes must attach to
CD4 molecules, how many must bind to coreceptors, and howmany
subunits per spike must participate in the entry process? These
quantitative aspects of viral entry are relevant to the development
and dosing of entry inhibitors as well as to vaccine design.
Current nomenclature classiﬁes an HIV-1 isolate as R5 tropic if
it uses the CCR5 co-receptor to enter a host cell, X4 tropic if it uses
the CXCR4 coreceptor, and dual tropic (X4R5) if it can utilize either
coreceptor for entry (Wyatt and Sodroski, 1998). Both X4 and R5
tropic gp120 subunits bind CD4 with a Kd of 4 nM but they bind
their respective coreceptors with different strengths. R5 gp120
binds CCR5 with a Kd of 4–15 nM while X4 gp120 binds CXCR4
with a Kd of 200–500 nM. X4R5 gp120 has a reduced ability to
bind both coreceptors (Zhang et al., 2004; Babcock et al., 2001;
Hoffman et al., 2000; Wu et al., 1996; Doranz et al., 1999). Target
cell prevalence also differs for X4 and R5 tropic forms of HIV-1
(Lee et al., 1999). It is possible that viruses with different tropisms
require different numbers of Env spikes to mediate entry or that
disabling subunits within a trimer has different effects on X4 vs.
R5 tropic viruses.
Electron microscopic studies show multiple entry spikes con-
tacting the target cell at the same time, but these studies cannot
reveal how many of the spikes are functional nor how many are
actively involved in the fusion process (Sougrat et al., 2007). Mole-
cular experiments, which commonly involve measuring the relative
infectivity of virions carrying a mixture of wild type and mutant
gp120 subunits, provide a way to analyze the role that individual
Env spikes and their subunits play in the HIV-1 entry process.
However, as Table 1 illustrates that these experiments have yielded
conﬂicting results (Magnus et al., 2009; Magnus and Regoes, 2010;
Klasse, 2007; Herrera et al., 2006; Yang et al., 2006, 2005a, 2005b).
This is mostly due to the different assumption each investigator
makes while modeling and to sparse data for infectivity curves.
Despite the efforts of several investigators, there is still no con-
sensus regarding the quantitative aspects of CD4 or coreceptor
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binding. Multiple mathematical models have been used to describe
the biophysical aspects of the entry process, but few of these models
have been directly compared. In this study, we present two models
that each use only three variables and make no assumptions about
the number of functional Env spikes a virion presents. Using these
models and new experimental relative infectivity curves, we have
reexamined the stoichiometry of HIV-1 entry.
Results
Model selection
Mathematical models have frequently been used to estimate the
stoichiometric parameters of HIV-1 entry (Magnus et al., 2009;
Magnus and Regoes, 2010; Klasse, 2007; Herrera et al., 2006; Yang
et al., 2006, 2005a, 2005b; Schønning et al., 1999; Kuhmann et al.,
2000). The basic equation that describes the relationship between
relative infectivity (RI%) and Env stoichiometry is RI%¼ ðPF ÞT 
100%; where PF is the probability that an Env spike is functional and
T is the minimum number of functional spikes required for viral
entry (Yang et al., 2005a). However, a virion may have more than the
required number of entry spikes. Including an additional term for
the average number of functional spikes on a virion ðntÞ allows us to
calculate the probability that a virion has at least T functional Env
spikes. The binomial distribution equation ∑nti ¼ T ðnt != nt ið Þ! i!Þ
 
PiF 1PFð Þnt  i describes the probability of having at least T functional
spikes given nt and PF. This expression would be sufﬁcient if the
probability of ﬁnding a functional spike (PF) was directly propor-
tional to the probability that a gp120 subunit is functional (pf ).
However, there are three gp120 subunits per spike and the effect of
disabling one or two subunits is unknown. Thus, to expand on the PF
term, we tested two equations that describe the way subunits
interact within a trimeric spike.
The ﬁrst model uses the incremental variable awhich describes
the degree of subunit independence (Herrera et al., 2006). The
equation PF¼a pf 3þpf (1a) calculates the probability that an
entry spike is functional (PF) using the term pf , the probability
that an Env subunit is functional (pf ). If a¼1, then the subunits are
completely dependent of one another and only trimers composed
of three functional subunits are active (PF¼pf 3). If a¼0 then the
subunits function independently and a spike loses one third of its
functional activity per mutant gp120 (PF¼pf ). Thus, if a¼0 then
the loss of one of the three functional gp120 subunits yields a
PF value that is 2/3 the value of all 3 being functional. An a value
greater than zero implies that disabling one subunit removes more
than one third of the binding ability of a spike. However, if ao0,
then disabling a subunit takes away less than one third of the
functional activity of the spike because the subunits are not only
independent, but can also compensate for each other to some
degree. The other term in the equation, pf , is modulated experi-
mentally by changing the ratio of wild type vs. mutant env vectors
transfected into the virus producing cells. Mathematically it is the
amount of wild type DNA divided by the total env DNA that was
used to generate that virus.
A second model describes PF in terms of the discreet variable
S: PF ¼∑3l ¼ 3Sð Þþ1 ð3!= 3 lð Þ! l!Þ
 
plf 1pf
 3 l
(Yang et al., 2005a).
The S variable can equal 1, 2, or 3. It relates to the degree of
compensation between subunits. If S¼1, then a single mutant
subunit will prevent any spike activity. If S¼2, then two functional
subunits are necessary and sufﬁcient for spike functionality. If
S¼3, a single gp120 subunit can compensate for the loss of the
other two. For purposes of comparison, a¼1 and S¼1 yield the
same PF result. The PF values generated by a¼0.5 models usually
match values between what S¼1 and S¼2 models predict (true if
pf40.2), and an a¼0.5 model consistently yields theoretical
PF values that lie between those predicted by S¼2 and S¼3
models.
As Fig. 1 illustrates, the two models (incremental a and discreet S)
yield predicted RI% curves with different shapes. The probability of
having a functional trimer (PF ) depends on pf in a manner that is
different for each model. In fact, the shape of each curve is unique to
its set of three variables, nt , T, and either a or S. Therefore, the
analysis of experimental RI% curves for virus preparations contain-
ing different fractions of mutant subunits (pf ) can yield insights into
the stoichiometry of HIV-1 entry. For example, as the fraction of
mutant gp120 increases, RI% falls, but it falls more quickly for lower
values of nt (Fig. 1A) and for higher values of T (Fig. 1B). This is
reasonable since with fewer total spikes and more required for entry,
Table 1
A simpliﬁed summary of HIV-1 stoichiometry studies.
Assumption Points per
infectivity curve
Experimental
ﬁndings
Target cell studied Method used
Kuhmann et al.
(2000)
nt and S not
accounted for
NA T¼2–6 HeLa CD4 cells Used mutations that reduced viral CCR5 binding ability and monitored
infectivity relative to coreceptor expression levels
Yang et al.
(2005a)
nt not accounted
for S¼1
6 T¼1 Cf2Th-CD4/CCR5 cells Mixing gp160 cleavage mutant or fusion peptide mutant and wild type
env, luciferase reporter
Yang et al.,
2005b
nt not accounted
for
3 T¼1 Cf2Th-CD4/CCR5 cells Mixing antibody sensitive and resistant env, luciferase reporter
S¼1
Yang et al.
(2006)
nt not accounted
for T¼1
4 S¼2 Cf2Th-CD4/CCR5 cells Mixing coreceptor/CD4 binding mutant and wild type env, luciferase
reporter
Herrera et al.
(2006)
nt¼9 S¼1 5 R5: T¼4 4:
T¼5
U87. CD4.CCR5 and U87.
CD4.CXCR4 cells
Mixing gp160 cleavage mutant with wild type env,
2nd model nt and T not
accounted for
R5: a¼14:
a¼ .365
Klasse (2007) nt¼9 No new data S¼1 NA Uses Yang (2005a), (2005b), 2006 and Herrera et al. (2006) data
T¼ 4–5
Magnus et al.
(2009)
nt¼1477 S¼1 No new data S¼1 NA Uses Yang et al., 2005b data
T¼2–9
Magnus and
Regoes
(2010)
nt¼1477 T¼8 No new data S¼1 NA Uses Yang et al. (2005a) data
T¼8
This study
2013
None 9 nt¼1–3 Primary CD4þT cells Mixing coreceptor/CD4 binding mutant and wild type env, GFP reporter
T¼1–2
S¼1–2
a¼varied
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the loss of functional subunits has a greater effect. Similarly,
infectivity falls more quickly when the subunits in a trimer are
highly dependent on one another (a¼1 or S¼1) (Fig. 1C and D).
Thus analysis of relative infectivity curves can provide insights into
Env stoichiometry.
Conﬁrming protein production and incorporation
The production of heterotrimers, consisting of wild type and
mutant Env subunits, has been conﬁrmed previously (Herrera et al.,
2006; Kuhmann et al., 2000; Salzwedel and Berger, 2009). To
demonstrate that the amount of DNA used in the transfections
directly corresponds to the amount of gp120 present in virions, we
ran Western blots on virus preparations produced with different
amounts of plasmid DNA. Fig. 2A shows that, for a representative R5
HIV-1 Env from the Yu2 isolate, gp120 protein (made with either
wild type or R315G/L317S mutant DNA) is incorporated at levels
that directly correspond to DNA input. Fig. 2B shows that the same
is true for representative X4 HIV-1 Env from the isolate HXB2, for
both the wild type and R308L mutant. A loading control is not
included because the samples are virus-containing supernatants,
removed from plates carrying adhered, transfected 293T cells. To
conﬁrm that mutant Env subunits mix with wild type subunits and
affect the shape of relative infectivity curves, we compared the virus
preparations made with and without mutant DNA. Fig. 2C shows
that for both Yu2 and HXB2 Envs, virus preparations generated with
equal amounts of wild type vector show reduced infectivity if
mutant vector is also present. This inhibitory effect is consistent
with reduced functional activity of mixed trimers containing both
wild type and mutant Env subunits.
Mutations affecting coreceptor binding
We ﬁrst explored the effects of including gp120 subunits that
were defective in binding to the CXCR4 (X4) or CCR5 (R5)
coreceptors. The mutant X4 tropic virus used was incapable of
supporting virus entry due to a single amino acid substitution
(R308L) in the V3 region, and the equally deﬁcient R5 tropic
mutant virus had two mutations (R315G/L317S) in the V3 loop
(Yang et al., 2006). Fig. 3A shows the relative infectivity curves of
chimeric virus preparations including these mutant gp120 sub-
units (Zarr, 2014). Infections were carried out in primary CD4þ T
lymphoblasts. As illustrated in Fig. 3A, chimeric viruses with a
fraction of coreceptor binding-deﬁcient gp120 subunits showed
reduced infectivity. The degree of reduction was similar for rep-
resentative R5 and X4 tropic viruses.
Mutations affecting CD4 binding
Similar experiments were performed with pseudoviruses carry-
ing mixtures of wild type gp120 and gp120 with mutations aff-
ecting CD4 binding. The previously described gp120 mutation
D368R was introduced into X4 tropic (HXB2) and R5 tropic (Yu2)
env vectors. This mutation disrupts a key salt bridge involved in CD4
binding (Yang et al., 2006). As expected, infectivity decreased as the
proportion of mutant subunits increased for both HXB2 and Yu2
viruses (Fig. 3B) (Zarr, 2014). Interestingly, for any given ratio of wild
type and mutant plasmids, relative infectivity was marginally lower
for viruses with HXB2 Env than for viruses with Yu2 Env (Fig. 3B),
meaning that viruses with the R5 Env Yu2may be slightly less affected
by the incorporation of CD4-binding deﬁcient gp120 subunits.
Fig. 1. Theoretical relative infectivity curves generated using various combinations of HIV-1 entry stoichiometric parameters. The relative infectivity curves representing the
results from theoretical systems with various stoichiometric parameters. The y-axis is the relative infectivity or the virus and the x-axis is the fraction of mutant DNA used is
virus generation (Pf). The equations were solved for fractions of mutant DNA from 0 to 1 at 0.1 intervals and graphed as solid lines. (A) The effect of varying nt. In this
example, nt¼1–5, T¼1 and S¼2. (B) The effect of varying T. The nt values are held constant at 5 and T ranges 1–5. (C) and (D) The effect of altering S and a. Note that S¼1
lines are not visible because they are identical to a¼1.
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Fitting relative infectivity curves to mathematical models of the HIV-1
entry process and determining best ﬁt
As discussed above, the shape of the relative infectivity curves
reﬂects the stoichiometry of molecular interactions necessary for
HIV-1 entry (Fig. 1). Using the equations described above, we gen-
erated theoretical relative infectivity curves for all combinations of
the variables: nt , the average number of entry spikes on a virion
(range nt¼1–30); T, the number of spikes required for entry (range
T¼1–30), and either a, a measure of subunit interdependence
(an incremental variable, range a¼0.5–1); or S, a measure of
the ability of individual subunits to compensate for each other
(a discrete variable with possible values 1, 2, 3).
We determined the theoretical curves’ goodness of ﬁt by
calculating the residual sum of squares. To generate conﬁdence
intervals we used 10,000 bootstrap samples per experimental data
set. Each of the nine points on each new curve was individually
generated by randomly sampling a population of relative infectiv-
ity (RI) values that had the same mean and standard deviation as
the corresponding experimental data point. Then, we determined
which theoretical curve best ﬁt each bootstrap sample. To generate
a 95% conﬁdence interval we included sets of best-ﬁt parameters
in descending order of frequency until at least 95% of bootstrap
samples were accounted for. Supplemental Table 1 lists all of the
theoretical curve parameters in the 95% conﬁdence interval.
Because there is experimental variation, and because the num-
ber of spikes per virus (nt) may also very, our 95% conﬁdence
interval includes many theoretical set of parameters. Thus, for ease
of comparison, Table 2 lists the stoichiometric parameters for the
eight theoretical curves that best matched the experimental
curves in Fig. 3. The table also shows the fraction of bootstrap
cases that ﬁt to each of those top eight parameters sets and how
much of the total bootstrap parameter distribution the top eight
best ﬁts account for. In the CD4 R5 data set, all parameter sets that
fall in the 95% conﬁdence interval are listed in Table 2. In fact, 9044
out of 10,000 of the best ﬁt curves (for CD4 R5) had nt¼2 and T¼1
values. The other data sets had more variation and thus the top
eight most common results represent smaller percentages of the
10,000 bootstrap curves.
Model comparison
Fig. 4 illustrates the curves from each model, incremental (a)
and discrete (S), which best matched each of the four experimental
data sets. In all of the data sets analyzed, the incremental (a)
model gave better ﬁts than the discrete (S) model. This may
indicate that entry spike function is not an all or none process
and that an incremental model is more accurate.
Best ﬁtting stoichiometric parameters
The most striking result is that entry appears to only require
one or two functional spikes. As seen in Fig. 1, the number of
spikes required for entry (T) has a large impact on the shape of a
theoretical relative infectivity curve. Fig. 5 is a graphical repre-
sentation of the data in Supplemental Table 1. Each bubble on the
plots represents a parameter pair (nt, T) and the size of the bubble
is proportional to the fraction of bootstrap samples that parameter
Fig. 2. Immunoblots and relative infectivity curve illustration gp120 production and incorporation. (A) and (B) Western blots showing the gp120 band. Equal amounts of
virus containing supernatants were loaded. Viruses were generated using 0.6 mg of pNL4–3Δenv DNA and the indicated amounts of expression vectors for the Env proteins
from HIV-1Yu2 (A) or HIV-1 HXB2 (B). (C) Relative infectivity of virus preparations made with equal amounts of wild type Env expression vectors, with or without mutant
Env expression vectors. Results are expressed as percent of maximal infection achieved with 0.3 mg wild type vector.
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pair ﬁts. This analysis shows that very low values of T most
frequently generated theoretical curves that matched the experi-
mental data. Similarly, our better ﬁtting model, the incremental
(a) model, suggests that the number of functional spikes/virion
(nt) is also low (2–4) (Fig. 5A–D).
For coreceptor binding, both HXB2 (X4) and Yu2 (R5) viruses
consistently utilize only one or two entry spikes. For YU2 entry into
primary CD4þ T cells, our experimental results are consistent with a
model in which a single functional spike is sufﬁcient for entry and
within that spike there is a moderate level of subunit interdepen-
dence. The HXB2 coreceptor binding data matches a model in
which either one or two spikes are necessary.
During the CD4 binding stage of the entry process, HXB2
viruses again appear to require only one or two spikes to attach
to the target cell while YU2 more clearly requires only one. It is
interesting to note that if two spikes are engaged, then fewer
active subunits per spike are required.
According to the discrete (S) model, there is no difference
between HXB2 (X4) and YU2 (R5) virus entry stoichiometry. While
the HXB2 and YU2 parameter values in the conﬁdence intervals of
the incremental (a) model do overlap, HXB2 (X4) virus seems
more likely to require two spikes than YU2 (R5).
The results in Table 2 also show a range of probable “S” and “a”
values. Differences in these variables represent different levels of
intra-spike interactions. The S model’s discrete values (1, 2 and 3)
correspond directly to the number of subunits a spike needs to
facilitate entry. For the incremental (a) model, the values for
subunits per spike are approximate ranges because, unlike the
discrete model (S), the incremental model does not ask a yes or no
question. The a variable indicates how well a spike can function
when a subunit is inactivated. High a values easily translate to a
3 subunits per spike requirement and indicates a high degree of
subunit interdependency. Lower a values indicate that the spike has
a high probability of functioning when one or two subunits are
inactive because the remaining subunit can compensate for the loss.
Discussion
In this paper, we present experimental relative infectivity
curves which elucidate the stoichiometry of CD4 and coreceptor
binding during HIV-1 entry. The data strongly support a model in
which a very low number of spikes are required for entry and
interaction between subunits in a trimer is complex. The analysis
of a larger set of Envs might provide additional insights into these
complex interactions.
Several previous reports have also investigated the entry stoi-
chiometry HIV-1 (Magnus et al., 2009; Magnus and Regoes, 2010;
Klasse, 2007; Herrera et al., 2006; Yang et al., 2006, 2005a, 2005b;
Schønning et al., 1999). However, it is difﬁcult to directly compare
the results of our study with those of other studies due to
differences in experimental design and modeling assumptions.
Our study, however, has several strengths; each relative infectivity
curve was generated with nine different pseudovirus preparations
carrying different ratios of wild type to mutant gp120 subunits.
Because of the number of points per curve, our analysis has
substantial predictive power that enables us to use equations with
three variables. In addition, we used two different types of mutants
(speciﬁc to either CD4 or coreceptor binding). Table 1 compares
nine stoichiometry studies, their assumptions, methods, and experi-
mental ﬁndings. Supplemental Fig. 1 compares our experimental
data with the theoretical curves that correspond to some of the
parameters suggested by other groups in Table 1.
A striking ﬁnding in the present study is the low number of
functional spikes per virion (nt). Other authors have reported
similar observations but the results have been controversial
Table 2
The stoichiometric parameters yielding the best ﬁtting theoretical relative infec-
tivity curves. The % column shows the fraction of the bootstrap parameter
distribution that each individual set of parameters represents. The Total % column
shows how much of the total bootstrap parameter distribution the top eight best
ﬁts account for.
Mutation Viral tropism Incremental “a” model Discrete “S” model
nt T a % Total % nt T S % Total %
Coreceptor X4 2 1 0.8 29 87 3 1 1 26 76
2 1 0.7 22 5 3 2 13
3 2 0.4 14 3 2 2 10
3 2 0.5 12 2 1 1 9
2 1 0.6 5 4 1 1 9
3 2 0.6 5 6 4 2 5
4 3 0.5 1 4 2 2 4
Coreceptor R5 2 1 0.6 20 76 4 2 2 15 57
2 1 0.5 17 5 2 2 8
2 1 0.7 16 3 1 1 8
2 1 0.4 10 2 1 2 7
2 1 0.8 5 4 1 1 7
2 1 0.3 5 3 1 2 6
3 2 0.4 2 6 3 2 6
CD4 X4 3 2 0.4 19 70 3 1 1 24 70
3 2 0.5 15 3 2 2 11
3 2 0.3 13 2 1 1 11
3 2 0.6 8 4 1 1 8
2 1 0.8 6 5 3 2 6
3 2 0.2 5 6 4 2 5
2 1 0.7 3 7 2 1 4
CD4 R5 2 1 0.5 31 96 4 2 2 25 70
2 1 0.6 29 5 2 2 12
2 1 0.4 16 3 1 2 8
2 1 0.7 10 5 1 1 7
2 1 0.3 4 4 1 1 7
3 2 0.1 3 6 1 1 6
3 2 0.2 2 7 3 2 5
Fig. 3. Relative infectivity curves comparing HIV-1HXB2 (X4) and HIV-1Yu2 (R5)
viruses. (A) and (B) Relative infectivity curves, the fraction of mutant DNA indicated
was used in virus production. (A) HIV-1Yu2 R315G/L317S mutant or HIV-1HXB2
R308L mutant DNA. (B) D368R mutant DNA, HIV-1HXB2 or HIV-1 Yu2.
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(Herrera et al., 2006; Yang et al., 2006, 2005a, 2005b. One reason
for the controversy is that electron tomography studies appear to
present a different picture. They show more than 1–3 spikes on
the surface of a virion, and they show HIV-1 Env trimers clustering
together on the virion surface to form “entry claws” (Sougrat et al.,
2007). An alternate interpretation of nt is that each “entry claw”
has only two or three functional spikes and the clustering of spikes
serves to increase the probability that the minimum number of
functional Env trimers will contact a cell. Additionally, a virus is
roughly spherical, and spikes that are not positioned or grouped
close enough to the site of cell contact may not be relevant to the
entry process. Thus our ﬁnding that nt is low may not mean that
there are only 2–3 entry spikes on a virion, but rather that there
are between 2 and 3 entry spikes that can, on average, simulta-
neously contact a target cell’s receptors.
Conclusion
Our study conﬁrms that HIV-1 requires only one or two functional
Env entry spikes in order to form an entry pore and infect a target
cell (T¼1 or 2). It also concludes that an individual virion, on average,
has either two or three spikes on its surface that are both functional
and able to simultaneously contact a target cell (nt¼2 or 3). In
addition, our analysis shows that Env trimers may function with
fewer than three active subunits. Subunit interaction is best modeled
using an incremental variable, and this indicates that subunit and
entry spike function is not an all or none process. These observations
together do not paint an optimistic picture for vaccine development;
in order to disable a virion, a drug or antibody needs to bind nearly
all of the subunits on all of the Env spikes. Finally, our analysis
indicates that, at least in reference to entry stoichiometry, there is at
most a minimal biophysical difference between HXB2 (X4 tropic) and
Yu2 (R5 tropic) viruses. The collections of best ﬁt parameters for each
virus overlap each other.
Methods
Mutants
We used a total of four different env mutants to make chimeric
viruses that express both wild type and mutant gp120. Previously
characterized mutations that prevent binding to CD4 (D368R) or to
coreceptors (R308L or R315G/L317S) (Yang et al., 2006) were intro-
duced into the reference isolates HIV-1HXB2 (X4 tropic) and HIV-
1Yu2 (R5 tropic) using the Quick Change Sight–Directed Mutagenesis
Kit (Invitrogen, Grand Island, NY). While the reference isolates
express the entire gp160 protein, in this paper we discuss the results
in terms of gp120 because only the gp120 portion is affected by the
mutations and is involved in the binding events of interest.
Generating chimeric virus
Relative infectivity assays were performed with pseudotyped
virions that carry heterotrimers of HIV-1 Env proteins composed of
wild-type gp120 subunits and gp120 subunits that are defective in
either CD4 or coreceptor binding. The assembly and virion incor-
poration of such heterotrimers has been conﬁrmed previously
(Herrera et al., 2006; Kuhmann et al., 2000; Salzwedel and Berger,
2009). We produced these chimeric pseudotyped viruses, which are
capable of only single-round infection, as previously described
(Zhang et al., 2004). Brieﬂy, we transfected HEK293T cells with a
GFP-tagged, Env-defective HIV-1 proviral vector (pNL43-ΔE-EGFP)
Fig. 4. Relative infectivity curves demonstrating the ﬁtting of the theoretical models. Experimental relative infectivity data for HXB2 ((A), (C), squares) and Yu2 ((B), (D),
diamonds).Virus preparations made with increasing fractions of mutant vectors encoding Env protein defective in coreceptor binding ((A), (B), solid symbols) or CD4 binding
mutant ((C), (D), open symbols). Experimental data are compared to the theoretical relative infectivity curves (colored lines) from the incremental (red) or discrete (blue)
models that best ﬁt the experimental data. (A) HIV-1HXB2 R308L mutant, incremental model: nt¼2 T¼1 a¼0.8; discrete model: nt¼4 T¼2 S¼2. (B) HIV-1Yu2 R315G/L317S
mutant, incremental model: nt¼2, T¼1, a¼0.6; discrete model: nt¼4, T¼2, S¼2. (C) HIV-1HXB2 D368R mutant, incremental model: nt¼3, T¼2, a¼0.4; discrete model:
nt¼4, T¼2, S¼2. (D) HIV-1Yu2 D368R mutant, incremental model: nt¼2, T¼1, a¼0.5; discrete model: nt¼4, T¼2 S¼2.
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Fig. 5. Bubble graphs illustrating the best ﬁtting nt and T values. Each point on a graph represents a parameter pair with nt on the x-axis and T on the y-axis. The size
of the point is proportional to the fraction of bootstrap samples that parameter pair ﬁt best. Graphs (A)–(D) show the ﬁtting results from the incremental (a) model and
graphs (E)–(H) show the discrete (S) model. Supplemental Table 1 lists the values presented on these graphs and also the corresponding a and S values.
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and either with a wild type HIV-1 Env expression vector (HIV-
1HXB2 or HIV-1Yu2) or with a mixture of wild type and mutant Env
expression vectors. By varying the ratio of wild type and mutant
DNA in the transfection mixture, we controlled the relative abun-
dance of wild type and mutant gp120 subunits in the viral entry
spikes. Nine ratios of wild type env DNA: mutant env DNA were
used, ranging from 9:1 to 1:9. Transfections were carried out using
Lipofectamine 2000 (Invitrogen, Grand Island, NY) according to the
manufacture’s protocol. The media was replaced 6 h after transfec-
tion, and cells were incubated at 37 1C for an additional 48 h before
the virus containing supernatant was added to target cells.
Single-round relative infectivity assay
We used a modiﬁed single-round infectivity assay to assess the
effect of mutant Env subunits on infectivity as previously described
(Zhang et al., 2004). Brieﬂy, peripheral blood mononuclear cells
were obtained from healthy blood donors by Hypaque-Ficoll gra-
dient centrifugation and then activated with phytohemagglutinin
(0.5 mg/ml) and interleukin-2 (100 U/ml) for 3 days. CD4þ T cells
were isolated by negative selection using antibody coated magnetic
beads (Miltenyi, Bergisch Gladbach, Germany) and seeded into a 96-
well plate at 1 105 cells per well in RPMI1640 supplemented with
10% fetal bovine serum, interleukin-2 (100 U/ml) and cytokine-rich
supernatant. Cells were infected using fresh pseudovirion prepara-
tions. To each well, 5–20 ml of virus containing supernatant was
added (sufﬁcient to produce 1–20% infection) and cells were
infected by spinoculation at 1200g, 30 1C for 2 h and further inc-
ubated at 37 1C for 3 days. All experiments were done in triplicate
with cells from at least three different donors, and virus from at least
three different preparations.
After the 3 day incubation, cells were washed, resuspended, and
ﬁxed with 3% formaldehyde. We quantiﬁed infectivity as the percen-
tage of GFPþ cells by FACS analysis (FACS Calibur, BD Bioscience)
(Kellam, 1994). All replicates, not means or medians, were used in the
curve matching and statistical analysis. All healthy blood donors gave
their written informed consent, and the study was approved by the
Institutional Review Board of Johns Hopkins University.
Western blots
For the analysis of HIV-1 gp120 expression, 293T cells were
transfected as described above with constant amounts of NL43
DNA and varying amounts of vectors containing either wild type or
mutant env. After 48 h of virus production time, the HIV-1 rich
supernatants were collected without disturbing the 293T cells.
Samples were prepared with NuPAGE LDS sample buffer according
to manufactures instructions (Invitrogen, Grand Island, NY) and 40 μl
of each was loaded and electrophoresed on a NuPAGE 4–12% Bis–tris
gell (NOVEX, Grand Island, NY) and then transferred to an Immun-
Blot PVDF membrane (Bio Rad, Hercules, CA). The blots were ﬁrst
probed with a primary antibody to HIV-1 gp120 (abcam, Cambridge,
UK) and then a horseradish peroxidase-conjugated rabbit anti- goat
antibody was added. The secondary antibody was detected through
autoradiography using enhanced chemiluminescence.
Curve matching
After FACS analysis, the percent relative infection (RI%) value for
each chimeric virus (nine virus preparations per curve, each with a
different ratio of mutant and wild type gp120 subunits) was
calculating by normalizing the percent infection to the infectivity
level of the wild-type virus. Then, a Matlab version 7.1 (TheMath-
Works) program was used to generate theoretical curves for all
combinations of the following variables within the indicated ranges:
nt , the average number of entry spikes on a virion (range nt¼1–30);
T, the number of spikes required for entry (range T¼1–30), and
either a, a measure of subunit interdependence (a continuous
variable, range a¼0.5–1, calculated at 0.1 intervals); or S, a
measure of the ability of individual subunits to compensate for each
other (a discreet variable with possible values 1, 2, 3). The shape of a
relative infectivity curve reﬂects the stoichiometry of the biological
process, and altering any of these parameters changes the shape of
the predicted curve (Fig. 1). The program compared each theoretical
curve to each experimental RI% curve and generated a goodness of
ﬁt statistic. Python was used to do the bootstrapping that generated
the conﬁdence intervals as described in Results section.
Author’s contributions
MZ conceived and performed the experiments and analyzed
the data. MZ wrote the manuscript. All authors read and approved
the ﬁnal manuscript.
Funding
This work was supported by HHMI and NIH/NIAID-R01 AI081600.
Acknowledgments
We thank the healthy blood donors for their participation and
the Siliciano lab for helpful conversations. We also thank Daniel
Rosenbloom and Max Morawski for their bootstrapping expertise.
Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.virol.2014.10.007.
References
Alkhatib, G., 2009. The biology of CCR5 and CXCR4. Curr. Opin. HIV AIDS 4, 96–103.
Babcock, G.J., Mirzabekov, T., Wojtowicz, W., Sodroski, J., 2001. Ligand binding
characteristics of CXCR4 incorporated into paramagnetic proteoliposomes.
J. Biol. Chem. 276, 38433.
Berger, E.A., 1988. A new classiﬁcation for HIV-1. Nature 17, 657–700.
Doranz, B.J., Baik, S.S.W., Doms, R.W., 1999. Use of a gp120 binding assay to dissect
the requirements and kinetics of human immunodeﬁciency virus fusion events.
J. Virol. 73, 10346–10358.
Herrera, C., Klasse, P.J., Kibler, C.W., Michael, E., Moore, J.P., Beddows, S., 2006. Dominant-
negative effect of hetero-oligomerization on the function of the human immuno-
deﬁciency virus type 1 envelope glycoprotein complex. J. Virol. 351, 121–132.
Hoffman, T.L., Canziani, G., Jia, L., Rucker, J., Doms, R.W., 2000. A biosensor assay for
studying ligand-membrane receptor interactions: binding of antibodies and
HIV-1 Env to chemokine receptors. Proc. Natl. Acad. Sci. U.S.A. 97, 11215.
Kellam, P., Larder, BA., 1994. Recombinant virus assay: a rapid, phenotypic assay for
assessment of drug susceptibility of human immunodeﬁciency virus type
1 isolates. Antimicrob. Agents Chemother. 38, 23–30.
Klasse, P.J., 2007. Modeling how many envelope glycoprotein trimers per virion
participate in human immunodeﬁciency virus infectivity and its neutralization
by antibody. J. Virol. 369, 245–262.
Kuhmann, S.E., Platt, E.J., Kozak, S.L., Kabat, D., 2000. Cooperation of multiple CCR5
coreceptors is required for infections by human immunodeﬁciency virus type 1.
J. Virol. 75 (15), 7005–7015.
LaBranche, C.C., Galasso, G., Moore, J.P., Bolognesi, D.P., Hirsch, M.S., Hammer, S.M.,
2001. HIV fusion and its inhibition. Antiviral Res. 50, 95–115.
Lee, B., Sharron, M., Montaner, L.J., Weissman, D., Doms, R.W., 1999. Quantiﬁcation
of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and
differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci.
U.S.A. 96, 5215–5220.
Magnus, C., Regoes, R.R., 2010. Estimating the stoichiometry of HIV neutralization.
PLoS Comput. Biol. 6 (3), e1000713.
Magnus, C., Rusert, P., Bonhoeffer, S., Trkola, A., Regoes, R.R., 2009. Estimating the
stoichiometry of human immunodeﬁciency virus entry. J. Virol. 83, 1523–1531.
Moore, J.P., Trkola, A., Dragic, T., 1997. Co-receptors for HIV-1 entry. Curr. Opin.
Immunol. 9, 551–562.
M. Zarr, R. Siliciano / Virology 474 (2015) 1–98
Moore, J.P., Kitchen, S.G., Pugach, P., Zack, J.A., 2004. Understanding the transmis-
sion and pathogenesis of human immunodeﬁciency virus type 1 infection. AIDS
Res. Hum. Retroviruses 20, 111–126.
Salzwedel, K., Berger, E.A., 2009. Complementation of diverse HIV-1 Env defects
through cooperative subunit interactions: a general property of the functional
trimer. Retrovirology 6, 75.
Schønning, K., Lund, O., Søgaard Lund, O., Hansen, J.E., 1999. Stoichiometry of
monoclonal antibody neutralization of T-cell line-adapted human immunode-
ﬁciency virus type 1. J. Virol. 73, 8364–8370.
Sougrat, R., Bartesaghi, A., Lifson, J.D., Bennett, A.E., Bess, J.W., Zabransky, D.J.,
Subramaniam, S., 2007. Electron tomography of the contact between T cells and
SIV/HIV-1: implications for viral entry. PLoS Pathog. 4 (5), e63 (3).
Wilen, C.B., Tilton, J.C., Doms, R.W., 2012. Molecular mechanisms of HIV entry.
Adv. Exp. Med. Biol. 726, 223–242.
Wu, L., Gerard, N.P., Wyatt, R., Choe, H., Parolin, C., Rufﬁng, N., Borsetti, A., Cardoso,
A.A., Desjardin, E., Newman, W., Gerard, C., Sodroski, J., 1996. CD4-induced
interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor
CCR-5. Nature 384, 179–183.
Wyatt, R., Sodroski, J., 1998. The HIV-1 envelope glycoproteins: fusogens, antigens,
and immunogens. Science 280, 1884–1888.
Yang, X., Kurteva, S., Lee, S., Sodroski, J., 2005a. Stoichiometry of antibody neutralization
of human immunodeﬁciency virus type 1. J. Virol. 79, 3500–3508.
Yang, X., Kurteva, S., Ren, X., Yang, S.L., Sodroski, J., 2005b. Stoichiometry of envelope
glycoprotein trimers in the entry of human immunodeﬁciency virus type 1. J. Virol.
79, 12132–12147.
Yang, X., Kurteva, S., Ren, X., Lee, S., Sodroski, J., 2006. Subunit stoichiometry of
human immunodeﬁciency virus type 1 envelope glycoprotein trimers during
virus entry into host cells. J. Virol. 80, 4388–4395.
Zarr M.A. (2014): Relative Infectivity Data Set for ﬁgs. 3 and 4. LabArchives. http://
dx.doi.org/10.6070/H4C53HS7.
Zhang, H., Zhou, Y., Alcock, C., Kiefer, T., Monie, D., Siliciano, J., Li, Q., Pham, P.,
Cofrancesco, J., Persaud, D., Siliciano, R.F., 2004. Novel single-cell-level pheno-
typic assay for residual drug susceptibility and reduced replication capacity of
drug-resistant human immunodeﬁciency virus type 1. J. Virol. 78, 1718–1729.
M. Zarr, R. Siliciano / Virology 474 (2015) 1–9 9
